Tvardi Therapeutics, Inc. (FRA:69C)
Germany · Delayed Price · Currency is EUR 2.645
-0.140 (-5.03%)
At close: Jan 30, 2026
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of €31.35 million as of January 30, 2026.
Market Cap
31.35M
Enterprise Value
851.75K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.65
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from 150.27M to 31.35M, a decrease of -79.14%. That is a compound annual growth rate of -86.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 31.35M | -8.76% |
| Dec 31, 2025 | 34.36M | -77.14% |
| Apr 16, 2025 | 150.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U.C.A. Aktiengesellschaft | 40.51M |
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 36.86M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 29.00M |
| Rubean AG | 27.29M |